pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Marketed
incobotulinumtoxinA
Xeomin (incobotulinumtoxinA)
Sialorrhoea
Merz Pharmaceuticals LLC
0
catalysts
Preclinical
incyclinide
Acute Lung Injury
CMTx Biotech Inc
0
catalysts
Marketed
indapamide
Indapamide (indapamide)
Edema
Rising Pharma Holdings Inc
0
catalysts
Marketed
← prev
page 186 of 231
next →
131
Pain
89
Neurology
1
indomethacin
Indomethacin (indomethacin)
Acute and Sub-Acute Bursitis
ACP Nimble Buyer Inc
0
catalysts
Marketed
indomethacin sodium
Indomethacin Sodium (indomethacin sodium)
Patent Ductus Arteriosus
Hikma Pharmaceuticals USA Inc
0
catalysts
Marketed
inebilizumab
Uplizna (inebilizumab)
Immunoglobulin G4-Related Disease (IgG4-RD)
Horizon Therapeutics USA Inc
0
catalysts
Marketed
infigratinib phosphate
Achondroplasia
Fibroblast growth factor receptor
QED Therapeutics Inc
0
catalysts
Marketed
infliximab
Remicade (infliximab)
Plaque Psoriasis (Psoriasis Vulgaris)
Janssen Biotech Inc
0
catalysts
Phase 3
influenza (quadrivalent) vaccine
Influenzavirus A Infections
$PFE
PFIZER INC
0
catalysts
Phase 3
influenza (trivalent) vaccine
Seasonal Influenza
$NVAX
NOVAVAX INC
0
catalysts
Phase 2
influenza [Strain H5] vaccine
Pandemic Influenza
$SNY
Sanofi
0
catalysts
Marketed
influenza [strains A/H1N1 + A/H3N2 + B/Victoria + B/Yamagata] (quadrivalent) vaccine
Flublok Quadrivalent
Influenza A Virus, H1N1 Subtype Infections
Sanofi Pasteur Inc
0
catalysts
Marketed
influenza [strains A/H1N1 + A/H3N2 + B/Victoria + B/Yamagata] (quadrivalent, split virion) vaccine
Flulaval Quadrivalent
Influenza A Virus, H1N1 Subtype Infections
GlaxoSmithKline Consumer Healthcare LP
0
catalysts
Marketed
influenza [strains A/H1N1 + A/H3N2 + B] (split virion) vaccine
Fluzone
Influenza A Virus, H1N1 Subtype Infections
Sanofi Pasteur Inc
0
catalysts
Marketed
influenza [strains A/H1N1 + A/H3N2 + B] (trivalent) vaccine
Flucelvax
Influenza A Virus, H1N1 Subtype Infections
Seqirus Ltd
0
catalysts
Marketed
influenza [strains A/H1N1 + A/H3N2 + B] (trivalent, split virion) vaccine
Afluria
Influenza A Virus, H1N1 Subtype Infections
Seqirus Ltd
0
catalysts
Preclinical
influenza [strains A/H1N1] vaccine
Influenza A Virus, H1N1 Subtype Infections
CEL-SCI Corp
0
catalysts
Marketed
influenza [types A and B] (quadrivalent) vaccine
Flucelvax Quadrivalent
Influenza A Virus, H1N1 Subtype Infections
Seqirus Ltd
0
catalysts
Phase 2
influenza vaccine 2
Unspecified Influenza Virus Infections
$JNJ
JOHNSON & JOHNSON
0
catalysts
Phase 2
inlexisertib
Gastrointestinal Stromal Tumor (GIST)
Deciphera Pharmaceuticals Inc
0
catalysts
Phase 2
inobrodib
Refractory Multiple Myeloma
CellCentric Ltd
0
catalysts
Preclinical
inotodiol
Duchenne Muscular Dystrophy
Animuscure Co Ltd
0
catalysts
Marketed
inotuzumab ozogamicin
Besponsa (inotuzumab ozogamicin)
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
$PFE
PFIZER INC
0
catalysts
pre_registration
insulin aspart biosimilar
Type 2 Diabetes
Tonghua Dongbao Pharmaceutical Co Ltd
0
catalysts
Preclinical
insulin biosimilar
Diabetes
Lamark Biotech Pvt Ltd
0
catalysts
Marketed
insulin degludec LA
Tresiba (insulin degludec)
Type 1 Diabetes (Juvenile Diabetes)
Novo Nordisk Inc
0
catalysts
Marketed
insulin detemir LA
Levemir (insulin detemir)
Type 1 Diabetes (Juvenile Diabetes)
Novo Nordisk Inc
0
catalysts
pre_registration
insulin efsitora alfa
Type 2 Diabetes
Eli Lilly and Co
0
catalysts
Marketed
insulin glulisine
Apidra (insulin glulisine)
Type 1 Diabetes (Juvenile Diabetes)
Sanofi-Aventis US LLC
0
catalysts
Marketed
insulin isophane
Humulin N (insulin isophane [INN])
Type 1 Diabetes (Juvenile Diabetes)
Lilly USA LLC
0
catalysts
